On June 3, 2025, InspireMD, Inc. held its annual meeting, with 20,478,807 shares (66.84%) voting; Michael Berman and Scott R. Ward were re-elected as directors and auditors appointed were ratified. The meeting confirmed 30,635,356 shares issued and outstanding.